Meeting News CoverageVideo

VIDEO: Rituximab effective in B-cell precursor ALL

ORLANDO, Fla. — Timothy Graubert, MD, offers insights into a plenary abstract presented at the ASH Annual Meeting that showed the addition of rituximab to the pediatric-inspired GRAALL protocol prolonged EFS among adults with CD20-positive, Philadelphia chromosome-negative acute lymphoblastic leukemia.

ORLANDO, Fla. — Timothy Graubert, MD, offers insights into a plenary abstract presented at the ASH Annual Meeting that showed the addition of rituximab to the pediatric-inspired GRAALL protocol prolonged EFS among adults with CD20-positive, Philadelphia chromosome-negative acute lymphoblastic leukemia.

    See more from ASH Annual Meeting and Exposition